OSA

Obstructive sleep apnea represents a critical yet frequently underdiagnosed secondary driver of metabolic dysfunction and endocrine pathology. This episode explores the complex bidirectional relationship between nocturnal hypoxia and endocrine systems, detailing how sleep fragmentation disrupts the hypothalamic-pituitary-adrenal axis, elevates cortisol levels, and induces severe insulin resistance.